Figure 1From: A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical prostatectomyAnalysis of Hazard Ratios. Hazard ratio comparisons with 95% confidence intervals for various PSADT thresholds for A) Biochemical Failure, B) Metastasis, C) Prostate cancer-specific mortality, D) Overall mortality.Back to article page